Abstract 341: VBC108: a first-in-class CDH17/CLDN18.2 targeted bispecific antibody drug conjugate (ADC) to overcome tumor heterogeneity of gastrointestinal cancers (GC, PADC, CRC, etc.)
用户PvNU_DSp92BA
6小时前
8
10
已关闭
DOI: 10.1158/1538-7445.am2025-341
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Wei (Vivian) Wang; Lingyu Guan; Man Xu; Qun Yin; Chen Dong; Jing Li
全文下载地址: https://aacrjournals.org/cancerres/article/85/8_Supplement_1/341/755159/Abstract-341-VBC108-a-first-in-class-CDH17-CLDN18